On roots of childhood asthma: The role of respiratory infections

Annals of Medicine

Volumn 37, Issue 1, 2005, Pages 26-32

  Remes, Sami T ^a,b   Korppi, Matti ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Asthma; Epidemiology; Infection; Selection bias

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1;

ASTHMA; BCG VACCINATION; BRONCHIOLITIS; CHILD; CHLAMYDOPHILA PNEUMONIAE; DEVELOPING COUNTRY; FINLAND; HEALTH CARE COST; HUMAN; HYGIENE; INCIDENCE; MATERNAL CARE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RHINOVIRUS; RISK FACTOR; SHORT SURVEY; TH1 CELL; TH2 CELL; UNITED STATES; URBANIZATION;

ANTIBODIES, BACTERIAL; ASTHMA; BACTERIA; CHILD; HUMANS; INCIDENCE; PREVALENCE; RESPIRATORY TRACT INFECTIONS; T-LYMPHOCYTES, HELPER-INDUCER; WORLD HEALTH;

EID: 14844315766     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890510007223     Document Type: Short Survey

References (67)

1. Haahtela T, Lindholm H, Bjorksten F, Koskenvuo K, Laitinen LA. Prevalence of asthma in Finnish young men. BMJ. 1990;301:266-8.
2. Yunginger JW, Reed CE, O'Connell EJ, Melton LJd, O'Fallon WM, Silverstein MD. A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983 [see comments]. Am Rev Respir Dis. 1992;146:888-94.
3. Peat J, Bjorksten B. Primary and secondary prevention of allergic asthma. Eur Respir J Suppl. 1998;27:28s-34s.
4. Lozano P, Sullivan SD, Smith DH, Weiss KB. The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol. 1999;104:957-63.
5. Klaukka T, Peura S, Martikainen J. Why has the utilization of antiasthmatics increased in Finland? J Clin Epidemiol. 1991;44:859-63.
6. Korhonen K, Reijonen TM, Remes K, Malmstrom K, Klaukka T, Korppi M. Reasons for and costs of hospitalization for pediatric asthma: a prospective 1-year follow-up in a population-based setting. Pediatr Allergy Immunol. 2001;12:331-8.
7. Anderson HR, Ruggles R, Strachan DP, Austin JB, Burr M, Jeffs D, et al. Trends in prevalence of symptoms of asthma, hay fever, and eczema in 12-14 year olds in the British Isles, 1995-2002: questionnaire survey. BMJ. 2004;328:1052-3.
8. Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J, Nissinen A. Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. Int J Epidemiol. 1994;23:495-504.
9. Pershagen G. Challenges in epidemiologic allergy research. Allergy. 1997;52:1045-9.
10. Pearce N, Sunyer J, Cheng S, Chinn S, Bjorksten B, Burr M, et al. Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood. Eur Respir J. 2000;16:420-6.
11. Martinez FD, Holt PG. Role of microbial burden in aetiology of allergy and asthma. Lancet. 1999;354:SII12-5.
12. Liu AH, Murphy JR. Hygiene hypothesis: fact or fiction? J Allergy Clin Immunol. 2003;111:471-8.
13. Centers for Disease Control, Achievements in public health, 1900-1999. Changes in the public health system. MMWR. 1999;48:1141-7.
14. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299:1259-60.
15. Pekkanen J, Remes S, Kajosaari M, Husman T, Soininen L. Infections in early childhood and risk of atopic disease. Acta Paediatr. 1999;88:710-4.
16. Ball TM, Castro-Rodriguez JA, Griffith KA, Holberg CJ, Martinez FD, Wright AL. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med. 2000;343:538-43.
17. Matricardi PM, Rosmini F, Riondino S, Fortini M, Ferrigno L, Rapicetta M, et al. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ. 2000;320:412-7.
18. Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, Grize L, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med. 2002;347:869-77.
19. Remes ST, Iivanainen K, Koskela H, Pekkanen J. Which factors explain the lower prevalence of atopy amongst farmers' children? Clin Exp Allergy. 2003;33:427-34.
20. Johnston SL. Viruses and asthma. Allergy. 1998;53:922-32.
21. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children [see comments]. Lancet. 1999;353:196-200.
22. Liu AH. Endotoxin exposure in allergy and asthma: Reconciling a paradox. J Allergy Clin Immunol. 2002;109:379-92.
23. Roy SR, Schiltz AM, Marotta A, Shen Y, Liu AH. Bacterial DNA in house and farm barn dust. J Allergy Clin Immunol. 2003;112:571-8.
24. Renzi PM, Turgeon JP, Marcotte JE, Drblik SP, Berube D, Gagnon MF, et al. Reduced interferon-gamma production in infants with bronchiolitis and asthma. Am J Respir Crit Care Med. 1999;159:1417-22.
25. Sorkness RL, Castleman WL, Kumar A, Kaplan MR, Lemanske RF, Jr. Prevention of chronic postbronchiolitis airway sequelae with IFN-gamma treatment in rats. Am J Respir Crit Care Med. 1999;160:705-10.
26. van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC.) 2nd., Welliver RC., Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol. 1999;103:630-6.
27. Halonen M, Martinez FD. A deficient capacity to produce interferon-gamma: is it a risk for asthma and allergies? [editorial; comment]. Clin Exp Allergy. 1997;27:1234-6.
28. Prescott SL. Early origins of allergic disease: a review of processes and influences during early immune development. Curr Opin Allergy Clin Immunol. 2003;3:125-32.
29. Simoes EA. Respiratory syncytial virus infection. Lancet. 1999;354:847-52.
30. Peebles RS, Jr. Viral infections, atopy, and asthma: is there a causal relationship? J Allergy Clin Immunol. 2004;113:S15-8.
31. Castro-Rodriguez JA, Holberg CJ, Wright AL, Halonen M, Taussig LM, Morgan WJ, et al. Association of radiologically ascertained pneumonia before age 3 yr with asthma-like symptoms and pulmonary function during childhood: a prospective study. Am J Respir Crit Care Med. 1999;159:1891-7.
32. Harding JE, Johnston BM. Nutrition and fetal growth. Reprod Fertil Dev. 1995;7:539-47.
33. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years [see comments]. Lancet. 1999;354:541-5.
34. Korppi M, Kuikka L, Reijonen T, Remes K, Juntunen-Backman K, Launiala K. Bronchial asthma and hyperreactivity after early childhood bronchiolitis or pneumonia. An 8-year follow-up study. Arch Pediatr Adolesc Med. 1994;148:1079-84.
35. Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM, Waris M, Korhonen K, Korppi M. Rhinovirus-induced wheezing in infancy-the first sign of childhood asthma? J Allergy Clin Immunol. 2003;111:66-71.
36. Guerra S, Wright AL, Morgan WJ, Sherrill DL, Holberg CJ, Martinez FD. Persistence of Asthma Symptoms during Adolescence: Role of Obesity and Age at Onset of Puberty. Am J Respir Crit Care Med. 2004;170:78-85.
37. Everard ML. What link between early respiratory viral infections and atopic asthma? [see comments]. Lancet. 1999;354:527-8.
38. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 1995;310:1225-9.
39. Rakes GP, Arruda E, Ingram JM, Hoover GE, Zambrano JC, Hayden FG, et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med. 1999;159:785-90.
40. Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med. 1996;154:654-60.
41. Papadopoulos NG, Bates PJ, Bardin PG, Papi A, Leir SH, Fraenkel DJ, et al. Rhinoviruses infect the lower airways. J Infect Dis. 2000;181:1875-84.
42. Juven T, Mertsola J, Waris M, Leinonen M, Meurman O, Roivainen M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 2000;19:293-8.
43. Bentley AM, Durham SR, Robinson DS, Menz G, Storz C, Cromwell O, et al. Expression of endothelial and leukocyte adhesion molecules interacellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. J Allergy Clin Immunol. 1993;92:857-68.
44. Parry DE, Busse WW, Sukow KA, Dick CR, Swenson C, Gern JE. Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol. 2000;105:692-8.
45. Papadopoulos NG, Stanciu LA, Papi A, Holgate ST, Johnston SL. A defective type 1 response to rhinovirus in atopic asthma. Thorax. 2002;57:328-32.
46. Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002;359:831-4.
47. Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ. 2002;324:763.
48. Tarlo SM, Broder I, Corey P, Chan-Yeung M, Ferguson A, Becker A, et al. The role of symptomatic colds in asthma exacerbations: Influence of outdoor allergens and air pollutants. J Allergy Clin Immunol. 2001;108:52-8.
49. Papadopoulos NG, Moustaki M, Tsolia M, Bossios A, Astra E, Prezerakou A, et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med. 2002;165:1285-9.
50. Hahn DL. Chlamydia pneumoniae, asthma, and COPD: what is the evidence? Ann Allergy Asthma Immunol. 1999;83:271-88, 291; quiz 291-2.
51. Gencay M, Rudiger JJ, Tamm M, Soler M, Perruchoud AP, Roth M. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med. 2001;163:1097-100.
52. Emre U, Roblin PM, Gelling M, Dumornay W, Rao M, Hammerschlag MR, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children [see comments]. Arch Pediatr Adolesc Med. 1994;148:727-32.
53. Korppi M, Paldanius M, Hyvärinen A, Nevalainen A, Husman T. Chlamydia pneumoniae and newly diagnosed asthma: a case-control study in 1 to 6-year-old children. Respirology. 2004;9:109-14.
54. Emre U, Sokolovskaya N, Roblin PM, Schachter J, Hammerschlag MR. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis. 1995;172:265-7.
55. Nagy A, Kozma GT, Keszei M, Treszl A, Falus A, Szalai C. The development of asthma in children infected with Chlamydia pneumoniae is dependent on the modifying effect of mannose-binding lectin. J Allergy Clin Immunol. 2003;112:729-34.
56. Martinez FD, Stern DA, Wright AL, Taussig LM, Halonen M. Differential immune responses to acute lower respiratory illness in early life and subsequent development of persistent wheezing and asthma. J Allergy Clin Immunol. 1998;102:915-20.
57. Von Hertzen L, Toyryla M, Gimishanov A, Bloigu A, Leinonen M, Saikku P, et al. Asthma, atopy and Chlamydia pneumoniae antibodies in adults. Clin Exp Allergy. 1999;29:522-8.
58. Cook PJ, Davies P, Tunnicliffe W, Ayres JG, Honeybourne D, Wise R. Chlamydia pneumoniae and asthma [see comments]. Thorax. 1998;53:254-9.
59. Esposito S, Principi N. Asthma in children: are chlamydia or mycoplasma involved? Paediatr Drugs. 2001;3:159-68.
60. Tuuminen T, Varjo S, Ingman H, Weber T, Oksi J, Viljanen M. Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays. Clin Diagn Lab Immunol. 2000;7:734-8.
61. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder [see comments]. Science. 1997;275:77-9.
62. Martinati LC, Boner AL. The inverse relationship between tuberculin responses and atopic disorder [letter] [see comments]. Allergy. 1997;52:1036-7.
63. Aim JS, Lilja G, Pershagen G, Scheynius A. Early BCG vaccination and development of atopy [see comments]. Lancet. 1997;350:400-3.
64. Strannegard IL, Larsson LO, Wennergren G, Strannegard O. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria [see comments]. Allergy. 1998;53:249-54.
65. Bjorksten B. Allergy priming early in life [comment]. Lancet. 1999;353:167-8.
66. von Hertzen LC, Haahtela T. Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper type 1 response? [see comments]. Am J Respir Cell Mol Biol. 2000;22:139-42.
67. Castro M, Chaplin DD, Walter MJ, Holtzman MJ. Could asthma be worsened by stimulating the T-helper type 1 immune response? [comment]. Am J Respir Cell Mol Biol. 2000;22:143-6.